Literature DB >> 2117679

Respiratory viruses and mycoplasma as cofactors for epidemic group A meningococcal meningitis.

P S Moore1, J Hierholzer, W DeWitt, K Gouan, D Djoré, T Lippeveld, B Plikaytis, C V Broome.   

Abstract

To investigate the role of coincident respiratory viral and mycoplasmal agents in the pathogenesis of meningococcal meningitis, we performed a matched case-control study of 62 patients with group A meningococcal meningitis during an epidemic in Chad. Case patients were more likely than controls to have nasal colonization or infection with respiratory viruses and Mycoplasma species (matched odds ratio, 23; 95% confidence interval, 3.1 to 170). Respiratory pathogens were found more commonly in older patients with meningitis (odds ratios were 2.9 for children under age 5 years and 46.5 in those over age 15 years), consistent with the increasing risk of meningitis with age during epidemics. In controls, the presence of respiratory pathogens increased the risk of upper-respiratory-tract symptoms but did not significantly increase meningococcal carriage.

Entities:  

Mesh:

Year:  1990        PMID: 2117679

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  44 in total

1.  Maternal cigarette smoking and invasive meningococcal disease: a cohort study among young children in metropolitan Atlanta, 1989-1996.

Authors:  H R Yusuf; R W Rochat; W S Baughman; P M Gargiullo; B A Perkins; M D Brantley; D S Stephens
Journal:  Am J Public Health       Date:  1999-05       Impact factor: 9.308

2.  Phenotypic and molecular characterization of serogroup C Neisseria meningitidis associated with an outbreak in Bahia, Brazil.

Authors:  Maria Cecília O Gorla; Ana Paula S de Lemos; Márcia Quaresma; Rita Vilasboas; Orgali Marques; Márcia U de Sá; Cinthya T Ogassavara; Maria Cristina de C Brandileone; Lee H Harrison; Juarez Dias
Journal:  Enferm Infecc Microbiol Clin       Date:  2011-11-09       Impact factor: 1.731

Review 3.  The immunopathogenesis of meningococcal disease.

Authors:  A J Kvalsvig; D J Unsworth
Journal:  J Clin Pathol       Date:  2003-06       Impact factor: 3.411

4.  Clonal and antigenic analysis of serogroup A Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in the People's Republic of China.

Authors:  J F Wang; D A Caugant; X Li; X Hu; J T Poolman; B A Crowe; M Achtman
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

5.  Meningococcal infections and the general practitioner.

Authors:  D Brewster
Journal:  Br J Gen Pract       Date:  1992-03       Impact factor: 5.386

6.  Modelling seasonal variations in the age and incidence of Kawasaki disease to explore possible infectious aetiologies.

Authors:  Virginia E Pitzer; David Burgner; Cécile Viboud; Lone Simonsen; Viggo Andreasen; Claudia A Steiner; Marc Lipsitch
Journal:  Proc Biol Sci       Date:  2012-03-07       Impact factor: 5.349

7.  Spatial dynamics of meningococcal meningitis in Niger: observed patterns in comparison with measles.

Authors:  N Bharti; H Broutin; R F Grais; M J Ferrari; A Djibo; A J Tatem; B T Grenfell
Journal:  Epidemiol Infect       Date:  2011-10-05       Impact factor: 2.451

Review 8.  Biology and pathogenesis of the evolutionarily successful, obligate human bacterium Neisseria meningitidis.

Authors:  David S Stephens
Journal:  Vaccine       Date:  2009-05-23       Impact factor: 3.641

Review 9.  Prospects for vaccine prevention of meningococcal infection.

Authors:  Lee H Harrison
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

10.  Pathogenesis, Therapy, and Prevention of Meningococcal Sepsis.

Authors:  David S. Stephens; Shanta M. Zimmer
Journal:  Curr Infect Dis Rep       Date:  2002-10       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.